Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEFOPAM vs NELFINAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NEFOPAM vs NELFINAVIR: Safety Overview

Metric NEFOPAM NELFINAVIR
Total FAERS Reports 2,857 1,164
Deaths Reported 360 87
Death Rate 12.6% 7.5%
Hospitalizations 1,685 162
Average Patient Age 55.0 yrs 40.8 yrs
% Female Patients 54.4% 32.4%
FDA Approval Date N/A Apr 30, 2003
Manufacturer N/A AGOURON
Route N/A ORAL
Marketing Status N/A Discontinued